The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Regional Brain Abnormalities Associated With Long-term Heavy Cannabis Use
Abstract
CONTEXT: Cannabis is the most widely used illicit drug in the developed world. Despite this, there is a paucity of research examining its long-term effect on the human brain. OBJECTIVE: To determine whether long-term heavy cannabis use is associated with gross anatomical abnormalities in 2 cannabinoid receptor-rich regions of the brain, the hippocampus and the amygdala. DESIGN: Cross-sectional design using high-resolution (3-T) structural magnetic resonance imaging. SETTING: Participants were recruited from the general community and underwent imaging at a hospital research facility. PARTICIPANTS: Fifteen carefully selected long-term (>10 years) and heavy (>5 joints daily) cannabis-using men (mean age, 39.8 years; mean duration of regular use, 19.7 years) with no history of polydrug abuse or neurologic/mental disorder and 16 matched nonusing control subjects (mean age, 36.4 years). MAIN OUTCOME MEASURES: Volumetric measures of the hippocampus and the amygdala combined with measures of cannabis use. Subthreshold psychotic symptoms and verbal learning ability were also measured. RESULTS: Cannabis users had bilaterally reduced hippocampal and amygdala volumes (P = .001), with a relatively (and significantly [P = .02]) greater magnitude of reduction in the former (12.0% vs 7.1%). Left hemisphere hippocampal volume was inversely associated with cumulative exposure to cannabis during the previous 10 years (P = .01) and subthreshold positive psychotic symptoms (P < .001). Positive symptom scores were also associated with cumulative exposure to cannabis (P = .048). Although cannabis users performed significantly worse than controls on verbal learning (P < .001), this did not correlate with regional brain volumes in either group. CONCLUSIONS: These results provide new evidence of exposure-related structural abnormalities in the hippocampus and amygdala in long-term heavy cannabis users and corroborate similar findings in the animal literature. These findings indicate that heavy daily cannabis use across protracted periods exerts harmful effects on brain tissue and mental health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“3) [10-32] NA NA Age started regular use, mean (SD) [range], yc 20.”
Background(1970) · Cited by 24,983
Fast robust automated brain extraction
Smith, S. M. (2002) · Human Brain Mapping · doi:10.1002/hbm.10062 · Cited by 10,496
Zhang, Y., Brady, M., & Smith, S. (2001) · IEEE Transactions on Medical Imaging · doi:10.1109/42.906424 · Cited by 6,982
Structured Clinical Interview for DSM-IV Axis I Disorders
Spitzer, R. L., First, M. B., & Gibbon, M. (1997) · Medical Entomology and Zoology · Cited by 4,086
Scale for the Assessment of Negative Symptoms (SANS)*
(1989) · British Journal of Psychiatry · doi:10.1192/s0007125000291502 · Cited by 2,701
Scale for Assessment of Positive Symptoms (SAPS) 1984
Andreasen, N. C. (1995) · Open Scholarship Institutional Repository (Washington University in St. Louis) · Cited by 2,423
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Cited by
The environment and schizophrenia
van Os, J., Kenis, G., & Rutten, B. P. F. (2010) · Nature · doi:10.1038/nature09563 · Cited by 1,572
Adverse health effects of non-medical cannabis use
Hall, W., & Degenhardt, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61037-0 · Cited by 1,134
Psychiatric Comorbidities and Schizophrenia
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn135 · Cited by 1,121
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3278 · Cited by 867
The neurobiology of psychopathic traits in youths
Blair, R. J. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3577 · Cited by 614
Hall, W. (2015) · Addiction · doi:10.1111/add.12703 · Cited by 579
Seely, K. A., Lapoint, J., Moran, J. H., & Fattore, L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.017 · Cited by 465
The Pharmacologic and Clinical Effects of Medical Cannabis
Borgelt, L. M., Franson, K. L., Nussbaum, A. M., & Wang, G. S. (2013) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1187 · Cited by 423
Batalla, A., Bhattacharyya, S., Yücel, M., Fusar-Poli, P., Crippa, J. A., Nogué, S., Torrens, M., Pujol, J., Farré, M., & Martin-Santos, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055821 · Cited by 416
Self-citationThe Chronic Effects of Cannabis on Memory in Humans: A Review
Solowij, N., & Battisti, R. (2008) · Current Drug Abuse Reviewse · doi:10.2174/1874473710801010081 · Cited by 380
Self-citationCannabis and adolescent brain development.
Lubman, D. I., Cheetham, A., & Yücel, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.009 · Cited by 360
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis
Davis, J., Eyre, H., Jacka, F. N., Dodd, S., Dean, O., McEwen, S., Debnath, M., McGrath, J., Maes, M., Amminger, P., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.017 · Cited by 355
Self-citationAge of Onset of Schizophrenia: Perspectives From Structural Neuroimaging Studies
Gogtay, N., Vyas, N. S., Testa, R., Wood, S. J., & Pantelis, C. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr030 · Cited by 344
Self-citationLong-Term Effects of Cannabis on Brain Structure
Battistella, G., Fornari, E., Annoni, J.-M., Chtioui, H., Dao, K., Fabritius, M., Favrat, B., Mall, J.-F., Maeder, P., & Giroud, C. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.67 · Cited by 342
The Myth of Schizophrenia as a Progressive Brain Disease
Zipursky, R. B., Reilly, T. J., & Murray, R. M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs135 · Cited by 334
Effect of long-term cannabis use on axonal fibre connectivity
Zalesky, A., Solowij, N., Yucel, M., Lubman, D. I., Takagi, M., Harding, I. H., Lorenzetti, V., Wang, R., Searle, K., Pantelis, C., et al. (2012) · Brain · doi:10.1093/brain/aws136 · Cited by 326
Self-citationCrane, N. A., Schuster, R. M., Fusar-Poli, P., & Gonzalez, R. (2013) · Neuropsychology Review · doi:10.1007/s11065-012-9222-1 · Cited by 309
Schreiner, A. M., & Dunn, M. E. (2012) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0029117 · Cited by 289
Cousijn, J., Wiers, R. W., Ridderinkhof, K. R., van den Brink, W., Veltman, D. J., & Goudriaan, A. E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.09.046 · Cited by 287
Long-term effects of marijuana use on the brain
Filbey, F. M., Aslan, S., Calhoun, V. D., Spence, J. S., Damaraju, E., Caprihan, A., & Segall, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415297111 · Cited by 249
Positive and Negative Effects of Cannabis and Cannabinoids on Health
Cohen, K., Weizman, A., & Weinstein, A. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1381 · Cited by 255
Yucel, M., Bora, E., Lubman, D. I., Solowij, N., Brewer, W. J., Cotton, S. M., Conus, P., Takagi, M. J., Fornito, A., Wood, S. J., et al. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq079 · Cited by 255
Self-citationGilman, J. M., Kuster, J. K., Lee, S., Lee, M. J., Kim, B. W., Makris, N., van der Kouwe, A., Blood, A. J., & Breiter, H. C. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4745-13.2014 · Cited by 250
“These exposure-dependent deformations may precede more pronounced volumetric changes, because others have reported a reduction in amygdala volumes in long-term, heavy users (Yücel et al., 2008; Schacht et al., 2012).”
BackgroundAdolescent cannabis use and psychosis: epidemiology and neurodevelopmental models
Malone, D. T., Hill, M. N., & Rubino, T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00721.x · Cited by 237
The Role of cannabinoids in neuroanatomic alterations in cannabis users.
Lorenzetti, V., Solowij, N., & Yücel, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.013 · Cited by 208
Self-citationWorth the wait: effects of age of onset of marijuana use on white matter and impulsivity
Gruber, S. A., Dahlgren, M. K., Sagar, K. A., Gönenç, A., & Lukas, S. E. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3326-z · Cited by 177
“2006; Schneider and Koch, 2003) and human (Yucel et al. 2008; Mata et al. 2010) studies.”
BackgroundAdolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence
Lorenzetti, V., Hoch, E., & Hall, W. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.03.012 · Cited by 166
Demirakca, T., Sartorius, A., Ende, G., Meyer, N., Welzel, H., Skopp, G., Mann, K., & Hermann, D. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.09.020 · Cited by 162
Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use
Ashtari, M., Cervellione, K., Cottone, J., Ardekani, B. A., & Kumra, S. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.12.002 · Cited by 159
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Burggren, A. C., Shirazi, A., Ginder, N., & London, E. D. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1634086 · Cited by 144
Kuepper, R., Morrison, P. D., van Os, J., Murray, R. M., Kenis, G., & Henquet, C. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.031 · Cited by 116
Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review
Batalla, A., Crippa, J. A., Busatto, G. F., Guimaraes, F. S., Zuardi, A. W., Valverde, O., Atakan, Z., McGuire, P. K., Bhattacharyya, S., & Martín-Santos, R. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990432 · Cited by 91
Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure
Pagliaccio, D., Barch, D. M., Bogdan, R., Wood, P. K., Lynskey, M. T., Heath, A. C., & Agrawal, A. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1054 · Cited by 77
Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder
D’Souza, D. C., Radhakrishnan, R., Naganawa, M., Ganesh, S., Nabulsi, N., Najafzadeh, S., Ropchan, J., Ranganathan, M., Cortes-Briones, J., Huang, Y., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00891-4 · Cited by 55
COMT val158met and 5-HTTLPR Genetic Polymorphisms Moderate Executive Control in Cannabis Users
Verdejo-García, A., Fagundo, A. B., Cuenca, A., Rodriguez, J., Cuyás, E., Langohr, K., de Sola Llopis, S., Civit, E., Farré, M., Peña-Casanova, J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.59 · Cited by 53
Functional connectivity and cannabis use in high-risk adolescents
Houck, J. M., Bryan, A. D., & Feldstein Ewing, S. W. (2013) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.837914 · Cited by 50
Midline brain structures in teenagers with first-presentation borderline personality disorder
Takahashi, T., Chanen, A. M., Wood, S. J., Walterfang, M., Harding, I. H., Yücel, M., Nakamura, K., McGorry, P. D., Suzuki, M., Velakoulis, D., et al. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.03.035 · Cited by 33
Self-citationLorenzetti, V., Kowalczyk, M., Duehlmeyer, L., Greenwood, L.-M., Chye, Y., Yücel, M., Whittle, S., & Roberts, C. A. (2023) · Cannabis & Cannabinoid Research · doi:10.1089/can.2021.0099 · Cited by 17
Self-citation
Metadata
- Authors
- Yücel, M., Solowij, N., Respondek, C., Whittle, S., Fornito, A., Pantelis, C., & Lubman, D. I.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2008-06-02
- Volume
- 65
- Issue
- 6
- Pages
- 694
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2144366004
- Cited by
- 497
- References
- 57
- FWCI
- 20.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.